Efficacy and safety of lenvatinib in an elderly patient with metastatic papillary thyroid carcinoma and cardiological comorbidity: a case report

被引：0

作者：

Latorre, Agnese ^{[1
]}

Fioretti, Agnese Maria ^{[2
]}

Giotta, Francesco ^{[1
]}

Lorusso, Vito ^{[1
]}

机构：

[1] Ist Tumori G Paolo II, UO Oncol Med, Bari, Italy

[2] Ist Tumori G Paolo II, UO Dipartimentale Cardiol, Bari, Italy

来源：

FUTURE ONCOLOGY | 2019年 / 15卷 / 24S期

关键词：

cardiological comorbidity; lenvatinib; papillary thyroid cancer; tyrosine kinase inhibitor; ATRIAL-FIBRILLATION; CANCER; INHIBITOR; MANAGEMENT; INTERVAL; FOCUS; QT;

D O I：

10.2217/fon-2019-0114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lenvatinib significantly prolonged progression-free survival versus placebo in patients with radio-iodine refractory differentiated thyroid carcinoma. However, the primary adverse effects of any grade that occurred in >40% of patients in the lenvatinib group of the Phase III SELECT trial was hypertension (67.8%). Therefore, this drug should be used with caution in patients with cardiological morbidity. Here, we describe the case of a 73-year-old man with hypertension, obesity and chronic atrial fibrillation, who received lenvatinib for 6 months in the absence of cardiological symptoms.

引用

页码：27 / 33

页数：7

共 50 条

[41] Tg developing in a pregnant patient with metastatic papillary thyroid carcinoma
Gessler, J.
Happel, C.
Kranert, W. T.
Middendorp, M.
Gruenwald, F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S410 - S410
[42] Case Report: Metastatic involvement of the acromioclavicular joint in a patient with papillary carcinoma of the ureter
Turemis, Cihangir
Celtik, Mustafa
Erduran, Mehmet
FRONTIERS IN SURGERY, 2025, 11
[43] ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN A PATIENT WITH PAPILLARY THYROID CARCINOMA: A CASE REPORT
Oreste, M.
Greco, N.
Imperatore, A.
Iannaccone, V. L.
Di Martino, M.
Fusco, C.
Savarese, R.
D'Angelo, V
Crisci, S.
Nobili, B.
Matarese, S. M. R.
Indolfi, P.
Casale, F.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S55 - S56
[44] A case report and literature review of rare isolated metastatic papillary thyroid carcinoma in the orbit
Khademi, Behzad
Zia, Zahra
THYROID RESEARCH, 2024, 17 (01)
[45] Thyroid storm caused by metastatic papillary thyroid carcinoma tissue after total thyroidectomy: a case report
Kwon, So Hee
Kim, Min-Ji
Jung, Sin Yeong
Jeon, Jae-Han
JOURNAL OF YEUNGNAM MEDICAL SCIENCE, 2023, 40 : S93 - S97
[46] Metastatic mastery- the uncommon journey of papillary thyroid carcinoma to the brain: a case report
Rana, Deeksha
Shukla, Samarth
Mishra, Preeti
Shrivastava, Priyal
Parihar, Pratapsingh
PAN AFRICAN MEDICAL JOURNAL, 2023, 45
[47] A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma
Takemura, Chihiro
Kashima, Jumpei
Hashimoto, Taiki
Ichikawa, Hitoshi
Honma, Yoshitaka
Goto, Yasushi
Watanabe, Shun-Ichi
Yatabe, Yasushi
HISTOPATHOLOGY, 2022, 80 (06) : 1004 - 1007
[48] Papillary Thyroid Microcarcinoma and Ectopic Papillary Thyroid Carcinoma in Mediastinum A Case Report
Piciu, Doina
Piciu, Andra
Irimie, Alexandru
CLINICAL NUCLEAR MEDICINE, 2012, 37 (02) : 214 - 215
[49] Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma
Nannini, Margherita
Repaci, Andrea
Ricco, Gianluca
Ianni, Manuela
Golemi, Arber
Maiolo, Vincenzo
Ferrari, Marco
Natali, Filippo
Rizzini, Elisa Lodi
Monari, Fabio
Solaroli, Erica
De Leo, Antonio
Maloberti, Thais
Pantaleo, Maria A.
De Biase, Dario
Tallini, Giovanni
FRONTIERS IN ONCOLOGY, 2022, 12
[50] Patient with parathyroid adenoma, thyroid toxic adenoma and metastatic papillary thyroid carcinoma
Brdar, D.
Punda, A.
Eterovic, D.
Soso, G.
Gracan, S.
Baric, A.
Kontic, M.
Markovic, V.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S384 - S385

← 1 2 3 4 5 →